| 000 | 01433 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250518063638.0 | ||
| 264 | 0 | _c20200528 | |
| 008 | 202005s 0 0 eng d | ||
| 022 | _a1879-0852 | ||
| 024 | 7 |
_a10.1016/j.ejca.2019.08.023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aScaranti, Mariana | |
| 245 | 0 | 0 |
_aDeep and sustained radiological response after MEK-RAF inhibition in HRAS mutant apocrine carcinoma of the scalp. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _c11 2019 |
||
| 300 |
_a9-11 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMAP Kinase Kinase Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins B-raf _xantagonists & inhibitors |
| 650 | 0 | 4 | _aScalp |
| 650 | 0 | 4 |
_aSweat Gland Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aNava Rodrigues, Daniel | |
| 700 | 1 | _aBanerji, Udai | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 122 _gp. 9-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2019.08.023 _zAvailable from publisher's website |
| 999 |
_c30190022 _d30190022 |
||